CFO appointment
Ocular Therapeutix, Inc. appoints Jason Robins as CFO
Ocular Therapeutix, Inc. reported in a Form 8-K filed June 12, 2026 that Jason Robins was appointed Chief Financial Officer, effective June 10, 2026.
In the filing's words
On June 10, 2026, the Board appointed Jason Robins, the Company’s interim Chief Financial Officer, to serve as the Chief Financial Officer. Mr. Robins is continuing to serve as the Company’s principal financial officer and principal accounting officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Ocular Therapeutix, Inc. (OCUL) |
|---|---|
| Event | Appointment |
| Incoming | Jason Robins |
| Title in the filing | Chief Financial Officer |
| Effective | June 10, 2026 |
| 8-K filed | June 12, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | interim Chief Financial Officer, OCULAR THERAPEUTIX, INC. |
| SEC CIK | 0001393434 |
Ocular Therapeutix, Inc. reported this change in a Form 8-K, Item 5.02, filed June 12, 2026. The filing's own words are quoted above.
Other records naming Jason Robins
1The incoming officer on this record, matched by name. Career line.
2026-02-05 · 10-K signature
Jason Robins signed Ocular Therapeutix, Inc.'s annual report as Interim Chief Financial Officer (Principal Financial and Accounting Officer)
Same industry, June 2026
8Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
5 months ago· 2026-06-18InterimMPLT
MapLight Therapeutics, Inc. names Jonathan Gillis interim CFO
5 months ago· 2026-06-18TransitionPTPI
Petros Pharmaceuticals, Inc. CFO transition: Robert Weinstein to succeed Mitchell Arnold
5 months ago· 2026-06-15AppointmentSNSE
Sensei Biotherapeutics, Inc. appoints Brian Stephenson as CFO
5 months ago· 2026-06-04AppointmentBYSI
BeyondSpring Inc. appoints Na Li as CFO
5 months ago· 2026-06-03InterimCVKD
Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jason Robins? Send a correction with the primary source.